Trial: 202006147

TITLE PAGE
A Phase II, Open-label, Study to Assess the Efficacy, Safety, and Tolerability of AZD4635 in Combination with Durvalumab and in Combination with Cabazitaxel and Durvalumab in Patients Who Have Progressive Metastatic Castrate-Resistant Prostate Cancer (AARDVARC)

Phase

II

Principal Investigator

Reimers, Melissa

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov